All visioneering technologies inc Articles
-
1.3KLatest Myopia NewsVTI’s PROTECT Study Reaches 100% Enrollment
December 7, 2022 ATLANTA — Visioneering Technologies Inc.’s PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) study has officially reached 100% participant enrollment....
-
1.7KClinicalWhat Can Chicken Eyes Tell Us About Using NaturalVue Multifocals?
sponsored content August 1, 2022 By Ashley Tuan, OD, PhD, FAAO Randomized controlled chicken studies have shown relative myopic defocus from a...
-
1.7KLatest Myopia NewsVTI’s NaturalVue Enhanced Multifocal Now Available in Canada
July 20, 2022 ATLANTA — Visioneering Technologies Inc.’s NaturalVue Enhanced Multifocal contact lenses are now available in Canada. The lenses feature the...
-
1.4KLatest Myopia NewsVTI’s Six-Year Clinical Trial Data Published in Clinical Ophthalmology
July 8, 2022 ATLANTA — Findings from Visioneering Technologies Inc.’s (VTI) six-year myopia management clinical trial were published in the Clinical Ophthalmology journal. The study...
-
1.8KImplementationVTI’s MyPath Education Initiative Enhanced My Myopia Practice
sponsored content June 15, 2022 By Andrew Brauer, OD The great thing about the MyPath resources is that there’s something in it...
-
1.3KLatest Myopia NewsTHE Myopia Meeting Returns Live In Person
May 20, 2022 COSTA MESA, Calif. — THE Myopia Meeting is back in person and returned with an all-day event here Sunday,...
-
3.1KLatest Myopia News
Registration Now Open for THE Myopia Meeting
Click here for the follow-up review of THE Myopia Meeting held in Costa Mesa, Calif., May 15, 2022. April 7, 2022 COSTA MESA,...
-
1.5KClinical
VTI’s CMO Dr. Ashley Tuan On NaturalVue and the PROTECT Study
sponsored content April 1, 2022 We believe that for myopia management, there needs to be a lot of tools in [the practitioner’s]...
-
2.3KProducts & ServicesVTI’s CMO Dr. Ashley Tuan on NaturalVue and the PROTECT Study
sponsored content March 15, 2022 Visioneering Technologies Inc. (VTI) has launched an international clinical trial that will test the efficacy of its...
-
1.9KLatest Myopia NewsVTI’s MyPath Myopia Education Initiative Now Available for ECPs
February 7, 2022 ATLANTA — Visioneering Technologies Inc.’s latest myopia management resource — the MyPath Myopia Education Initiative — is now available...
-
2.2KLatest Myopia NewsVTI Begins International Myopia Control Clinical Trial of NaturalVue Lenses
January 24, 2022 ATLANTA — Visioneering Technologies Inc. announced that it has begun its international clinical trial that is designed to test...
-
2.8KLatest Myopia NewsVTI Releases NaturalVue Data, Unveils Enhanced Multifocal, and Names CMO
November 4, 2021 BOSTON — During a press event at the American Academy of Optometry’s (AAO) 2021 meeting, Visioneering Technologies Inc. (VTI)...
-
5.6KClinicalSimplicity is Key When Talking to Parents About Myopia Management
sponsored content October 1, 2021 By Brett O’Connor, OD, FAAO There’s no one right way to have these discussions with patients. However,...
-
3.2KLatest Myopia NewsVTI Adds ABB Optical Group Canada as Authorized NaturalVue Distributor
August 5, 2021 ATLANTA — Visioneering Technologies, Inc. (VTI) announced that ABB Optical Group Canada will be an authorized distributor of NaturalVue...
-
2.1KLatest Myopia NewsVTI Announces New Partnership with Innovatus Technology
July 28, 2021 ATLANTA, Ga. and ADELAIDE, South Australia — Visioneering Technologies, Inc. (VTI) has partnered with orthokeratology company Innovatus Technology Pty...
-
2.5KResources & MultimediaVTI Announces Upcoming RCT in New Video Interview
July 26, 2021 ALPHARETTA, Ga. – In this new video interview with Visioneering Technologies, Inc. (VTI), CEO Dr. Stephen Snowdy shares the news,...
-
2.4KLatest Myopia NewsVTI’s NaturalVue Sustains Business for ECPs During Pandemic
June 7, 2021 ATLANTA – U.S.-based medical device company and producer of the NaturalVue (etafilcon A) Multifocal 1 Day Contact Lenses, Visioneering Technologies,...